Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Ixazomib, Thalidomide and Dexamethasone (IxaThalDex) in Relapsed/Refractory Multiple Myeloma (RRMM): An Interim Analysis of a Phase II Trial

Heinz Ludwig, MD, Eberhard Gunsilius, MD, Michael Fridrik, MD, Richard Greil, Andreas Petzer, MD, Thomas Kühr, Univ. Doz. Dr., Stefan Knop, MD, Martin Schreder, MD, Elisabeth Rauch, Mag., Wolfram Poenisch, MD, Niklas Zojer, MD

Blood (2016) 128 (22): 3335.

https://doi.org/10.1182/blood.V128.22.3335.3335

Published: 2016

Journal Articles

High Blood BAALC Copy Numbers Determined By Digital Droplet PCR at Timepoint of Allogeneic Transplantation in Complete Remission Predicts Relapse in Patients with Acute Myeloid Leukemia

Madlen Jentzsch, MD, Marius Bill, MDPhD, Julia Schulz, Juliane Grimm, Stefanie Beinicke, Karoline Schubert, Janine Haentschel, Kathrin Wildenberger, Laura Katharina Schmalbrock, MD, Lynn Baquiran Bonifacio, MD, Wolfram Poenisch, MD, Gerhard Behre, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 517.

https://doi.org/10.1182/blood.V128.22.517.517

Published: 2016

Journal Articles

High Expression of ZBTB7A at Diagnosis Associated with Inferior Outcome in Acute Myeloid Leukemia Patients Receiving Hematopoietic Stem Cell Transplantation

Juliane Grimm, Madlen Jentzsch, MD, Marius Bill, MD PhD, Julia Schulz, Karoline Schubert, Stefanie Beinicke, Janine Haentschel, Luba Schuhmann, Michael Cross, PhD, Vladan Vucinic, MD, Wolfram Poenisch, MD, Gerhard Behre, MD, Georg-Nikolaus Franke, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 5092.

https://doi.org/10.1182/blood.V128.22.5092.5092

Published: 2016

Journal Articles

Biological Associations and Clinical Impact of Differential Expression of the Pre- Mir-29a/b-1 and P re -Mir-29b-2/C Clusters in Acute Myeloid Leukemia

Florian Ramdohr, MD, Marius Bill, MD PhD, Madlen Jentzsch, MD, Karoline Schubert, Juliane Grimm, Julia Schulz, Luba Schuhmann, Laura Katharina Schmalbrock, MD, Lynn Baquiran Bonifacio, MD, Stefanie Beinicke, Janine Haentschel, Wolfram Poenisch, MD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 5110.

https://doi.org/10.1182/blood.V128.22.5110.5110

Published: 2016

Journal Articles

Absolute Quantification of Pre- microRNA-155 Copy Numbers By Digital Droplet PCR Identifies Acute Myeloid Leukemia (AML) Patients with Adverse Outcome

Marius Bill, MD PhD, Madlen Jentzsch, MD, Julia Schulz, Karoline Schubert, Juliane Grimm, Laura Katharina Schmalbrock, MD, Lynn Baquiran Bonifacio, MD, Stefanie Beinicke, Janine Haentschel, Wolfram Poenisch, MD, Gerhard Behre, MD, Vladan Vucinic, MD, Thoralf Lange, MD, Georg-Nikolaus Franke, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 1698.

https://doi.org/10.1182/blood.V128.22.1698.1698

Published: 2016

Journal Articles

High Expression of the Hedgehog Transcription Factor GLI1 Is Associated with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Non-Myeloablative Conditioning

Marius Bill, MDPhD, Madlen Jentzsch, MD, Luba Schuhmann, Juliane Grimm, Maria Knyrim, Laura Katharina Schmalbrock, MD, Schubert Karoline, Michael Cross, PhD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Wolfram Poenisch, MD, Gerhard Behre, MD, Thoralf Lange, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 2032.

https://doi.org/10.1182/blood.V126.23.2032.2032

Published: 2015

Journal Articles

Higher Incidence of Secondary AML and Adverse Molecular Markers, Together with Lower CR and Higher AML Related Death Rates in Elderly Compared to Younger Patients: Results from 2435 Patients Included in the Two German AML Intergroup Studies

Blood (2015) 126 (23): 2517.

https://doi.org/10.1182/blood.V126.23.2517.2517

Published: 2015

Journal Articles

Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Madlen Jentzsch, MD, Luba Schuhmann, Marius Bill, MDPhD, Sabine Leiblein, PhD, Ulrike Bergmann, Martina Pless, Karoline Schubert, Laura Katharina Schmalbrock, MD, Juliane Grimm, Maria Knyrim, Wolfram Poenisch, MD, Georg-Nikolaus Franke, MD, Vladan Vucinic, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 2573.

https://doi.org/10.1182/blood.V126.23.2573.2573

Published: 2015

Journal Articles

Prognostic Impact of Aberrant RUNX1 Expression in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Maria Knyrim, Madlen Jentzsch, MD, Marius Bill, MDPhD, Juliane Grimm, Karoline Schubert, Michael Cross, PhD, Georg-Nikolaus Franke, MD, Wolfram Poenisch, MD, Vladan Vucinic, MD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 3829.

https://doi.org/10.1182/blood.V126.23.3829.3829

Published: 2015

Journal Articles

Assessment of NPM1 Type a Mutation Burden By Digital Droplet PCR As a Marker of Minimal Residual Disease in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Juliane Grimm, Marius Bill, MDPhD, Laura Kloss, Madlen Jentzsch, MD, Maria Knyrim, Karoline Schubert, Christine Guenther, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Wolfram Poenisch, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 4398.

https://doi.org/10.1182/blood.V126.23.4398.4398

Published: 2015

Journal Articles

Impact of Comorbidities and Prospective Functional Geriatric Assessment Tools (CF-GA) As an Aide to Understand Outcome, Therapy Tolerance, Side Effects and Clinical Trial Eligibility in Multiple Myeloma (MM) Patients (pts)

Alexander Zober, MD, Mandy Möller, Sandra-Maria Dold, Gabriele Ihorst, PhD, Stefanie Hieke, PhD, Jochen Knaus, Milena Pantic, PhD, Barbara Deschler-Baier, MD, Stefan Knop, Hermann Einsele, Christian Langer, Lars-Olof Muegge, MD, Wolfram Poenisch, MD, Justus Duyster, MD PhD, Martin Schumacher, PhD, Ralph M. Waesch, MD PhD, Monika Engelhardt, MD PhD

Blood (2015) 126 (23): 5616.

https://doi.org/10.1182/blood.V126.23.5616.5616

Published: 2015

Journal Articles

Inclusion of Plerixafor Increases the Efficacy of Stem Cell Harvesting in Poorly Mobilizing Patients with Multiple Myeloma and Lymphoma

Madlen Jentzsch, MD, Elena Ruschpler, Sabine Leiblein, PhD, Yvonne Remane, Jan-Phillip Stümpel, MD, Georg-Nikolaus Franke, MD, Simone Heyn, MD, Nadja Jaekel, MD, Susann Schulze, MD, Song-Yau Wang, MD, Wolfram Poenisch, MD, Claudia Nehring, MD, Sebastian Schwind, MD, Dietger Niederwieser, MD, Vladan Vucinic, MD

Blood (2015) 126 (23): 5439.

https://doi.org/10.1182/blood.V126.23.5439.5439

Published: 2015

Journal Articles

Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study

Heinz Ludwig, Univ. Prof. Dr., Elisabeth Rauch, Thomas Kuehr, MD, Adam Zdenek, MD, Adalbert Weissmann, MD, Hedwig Kasparu, MD, Eva-Maria Autzinger, MD, Daniel Heintel, MD, Richard Greil, MD, Wolfram Poenisch, MD, Niklas Zojer, MD, Ercan Müldür, MD

Blood (2014) 124 (21): 3484.

https://doi.org/10.1182/blood.V124.21.3484.3484

Published: 2014

Journal Articles

Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation - a Treatment Option in Elderly or Comorbid Patients with Acute Lymphatic Leukemia

Vladan Vucinic, MD, Theresa Tumewu, Georg-Nikolaus Franke, MD, Sebastian Schwind, MD, Nadja Jaekel, MD, Simone Heyn, MD, Wolfram Poenisch, MD, Haifa Kathrin Al-Ali, MD, Sabine Leiblein, Rainer Krahl, PhD, Madlen Jentzsch, MD, Gerhard Behre, MD, Dietger Niederwieser, MD

Blood (2014) 124 (21): 5945.

https://doi.org/10.1182/blood.V124.21.5945.5945

Published: 2014

Journal Articles

Successful Stem Cell Mobilization and Autologous Stem Cell Transplantation after Pretreatment Consisting of Bendamustine, Prednisone and Bortezomib (BPV) in 35 Patients with Newly Diagnosed/Untreated Multiple Myeloma

Blood (2014) 124 (21): 5900.

https://doi.org/10.1182/blood.V124.21.5900.5900

Published: 2014

Journal Articles

Increasing The Dose Of AraC In Consolidation Therapy Does Not Lead To Higher Overall Survival Or Improved Relapse Incidence In Patients With AML Over The Age Of 60 Years

Blood (2013) 122 (21): 2645.

https://doi.org/10.1182/blood.V122.21.2645.2645

Published: 2013

Journal Articles

Outcome Of MDS and AML With MDS-Related Changes: Treatment Versus Prognostic Factors

Nadja Jaekel, Susann Schulze, Cora Graneist, Rainer Krahl, PhD, Wolfram Poenisch, MD, Thoralf Lange, Vladan Vucinic, MD, Georg Franke, MD, Christian Pfrepper, Dietger Niederwieser, MD, Haifa Kathrin Al-Ali, MD

Blood (2013) 122 (21): 5223.

https://doi.org/10.1182/blood.V122.21.5223.5223

Published: 2013

Journal Articles

Prognostic Significance Of EVI1 expression In Acute Myeloid Leukemia Patients With Intermediate and Adverse Cytogenetic Risk Undergoing Allogeneic Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Marius Bill, PhD, Madlen Jentzsch, MD, Thoralf Lange, MD, Laura Kloss, Rainer Krahl, PhD, Georg Franke, MD, Stephan Fricke, MD, Vladan Vucinic, MD, Wolfram Poenisch, MD, Haifa Kathrin Al-Ali, MD, Gerhard Behre, MD, Michael Cross, PhD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2013) 122 (21): 3383.

https://doi.org/10.1182/blood.V122.21.3383.3383

Published: 2013

Journal Articles

Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Haifa K. Al-Ali, MD, Claudia Nehring, MD, Rainer Krahl, PhD, Cornelia Becker, MD, Sabine Leiblein, PhD, Jeanett Edelmann, PhD, Wolfram Poenisch, MD, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2007) 110 (11): 1654.

https://doi.org/10.1182/blood.V110.11.1654.1654

Published: 2007

Journal Articles

Bortezomib in Combination with Bendamustine and Prednisone in the Treatment of Patients with Refractory/Relapsed Multiple Myeloma.

Wolfram Poenisch, MD, Malvina Bourgeois, Song-Yau Wang, Simone Heyn, Nadja Jaekel, Leanthe Braunert, Robert Rohrberg, MD, Hans Juergen Hurtz, MD, Franz Albert Hoffmann, MD, Andreas Schwarzer, MD, Cornelia Becker, MD, Haifa Al Ali, MD, Dietger W. Niederwieser, MD

Blood (2007) 110 (11): 2723.

https://doi.org/10.1182/blood.V110.11.2723.2723

Published: 2007

NARROW

Ixazomib, Thalidomide and Dexamethasone (IxaThalDex) in Relapsed/Refractory Multiple Myeloma (RRMM): An Interim Analysis of a Phase II Trial

High Blood BAALC Copy Numbers Determined By Digital Droplet PCR at Timepoint of Allogeneic Transplantation in Complete Remission Predicts Relapse in Patients with Acute Myeloid Leukemia

High Expression of ZBTB7A at Diagnosis Associated with Inferior Outcome in Acute Myeloid Leukemia Patients Receiving Hematopoietic Stem Cell Transplantation

Biological Associations and Clinical Impact of Differential Expression of the Pre- Mir-29a/b-1 and P re -Mir-29b-2/C Clusters in Acute Myeloid Leukemia

Absolute Quantification of Pre- microRNA-155 Copy Numbers By Digital Droplet PCR Identifies Acute Myeloid Leukemia (AML) Patients with Adverse Outcome

High Expression of the Hedgehog Transcription Factor GLI1 Is Associated with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Non-Myeloablative Conditioning

Higher Incidence of Secondary AML and Adverse Molecular Markers, Together with Lower CR and Higher AML Related Death Rates in Elderly Compared to Younger Patients: Results from 2435 Patients Included in the Two German AML Intergroup Studies

Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Prognostic Impact of Aberrant RUNX1 Expression in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Assessment of NPM1 Type a Mutation Burden By Digital Droplet PCR As a Marker of Minimal Residual Disease in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Impact of Comorbidities and Prospective Functional Geriatric Assessment Tools (CF-GA) As an Aide to Understand Outcome, Therapy Tolerance, Side Effects and Clinical Trial Eligibility in Multiple Myeloma (MM) Patients (pts)

Inclusion of Plerixafor Increases the Efficacy of Stem Cell Harvesting in Poorly Mobilizing Patients with Multiple Myeloma and Lymphoma

Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study

Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation - a Treatment Option in Elderly or Comorbid Patients with Acute Lymphatic Leukemia

Successful Stem Cell Mobilization and Autologous Stem Cell Transplantation after Pretreatment Consisting of Bendamustine, Prednisone and Bortezomib (BPV) in 35 Patients with Newly Diagnosed/Untreated Multiple Myeloma

Increasing The Dose Of AraC In Consolidation Therapy Does Not Lead To Higher Overall Survival Or Improved Relapse Incidence In Patients With AML Over The Age Of 60 Years

Outcome Of MDS and AML With MDS-Related Changes: Treatment Versus Prognostic Factors

Prognostic Significance Of EVI1 expression In Acute Myeloid Leukemia Patients With Intermediate and Adverse Cytogenetic Risk Undergoing Allogeneic Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Bortezomib in Combination with Bendamustine and Prednisone in the Treatment of Patients with Refractory/Relapsed Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only